Traditionally, viruses have been thought of as a burden that cause disease. Now, viruses are being harnessed to tackle ...

Florida Cancer Specialists & Research Institute, LLC (FCS), a leader in pharmacy services within medically integrated oncology care, will share its expertise and best practices in specialty pharmacy ...

Key advancements in Verrica’s pipeline include positive data from a Phase 2 study of VP-315, an oncolytic peptide candidate targeting basal cell carcinoma. Additionally, the company plans to ...

The company also develops VP-315, an oncolytic peptide-based injectable therapy, which is in phase II clinical trial for the treatment of dermatology oncologic conditions which includes basal cell ...

Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the company inked with Austria-based drug delivery technology maker Cyprumed.

Peptides are smaller versions of proteins. They may provide pro-aging support, anti-inflammatory, or muscle-building properties. However, more research is still necessary to understand their risks ...